Aptose Biosciences Inc.·4

Sep 21, 6:07 PM ET

Rice William G. 4

4 · Aptose Biosciences Inc. · Filed Sep 21, 2022

Insider Transaction Report

Form 4
Period: 2022-09-19
Rice William G.
DirectorChair, President & CEO
Transactions
  • Purchase

    Common Shares

    2022-09-19$0.68/sh+10,000$6,834363,252 total
Footnotes (1)
  • [F1]The purchase price reported in Column 4 represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6834 to $0.6835, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.

Documents

2 files
  • 4
    doc1.xmlPrimary

    FORM 4

  • EX-24.2

    POWER OF ATTORNEY